GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Poly Medicure Ltd (BOM:531768) » Definitions » Cyclically Adjusted Revenue per Share

Poly Medicure (BOM:531768) Cyclically Adjusted Revenue per Share : ₹111.03 (As of Mar. 2025)


View and export this data going back to 1996. Start your Free Trial

What is Poly Medicure Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Poly Medicure's adjusted revenue per share for the three months ended in Mar. 2025 was ₹42.675. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ₹111.03 for the trailing ten years ended in Mar. 2025.

During the past 12 months, Poly Medicure's average Cyclically Adjusted Revenue Growth Rate was 10.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2025-05-30), Poly Medicure's current stock price is ₹2259.25. Poly Medicure's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 was ₹111.03. Poly Medicure's Cyclically Adjusted PS Ratio of today is 20.35.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Poly Medicure was 29.39. The lowest was 15.43. And the median was 21.28.


Poly Medicure Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Poly Medicure's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Poly Medicure Cyclically Adjusted Revenue per Share Chart

Poly Medicure Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 100.42 111.03

Poly Medicure Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 100.42 104.10 107.61 109.76 111.03

Competitive Comparison of Poly Medicure's Cyclically Adjusted Revenue per Share

For the Medical Instruments & Supplies subindustry, Poly Medicure's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Poly Medicure's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Poly Medicure's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Poly Medicure's Cyclically Adjusted PS Ratio falls into.


;
;

Poly Medicure Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Poly Medicure's adjusted Revenue per Share data for the three months ended in Mar. 2025 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=42.675/157.5517*157.5517
=42.675

Current CPI (Mar. 2025) = 157.5517.

Poly Medicure Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201103 0.000 70.768 0.000
201203 0.000 76.889 0.000
201206 6.423 79.567 12.718
201209 6.956 82.244 13.325
201212 6.952 83.774 13.074
201303 8.595 85.687 15.804
201403 0.000 91.425 0.000
201503 0.000 97.163 0.000
201603 0.000 102.518 0.000
201703 0.000 105.196 0.000
201712 14.373 109.404 20.698
201803 15.626 109.786 22.424
201806 15.105 111.317 21.379
201809 17.015 115.142 23.282
201812 17.536 115.142 23.995
201903 17.213 118.202 22.943
201906 18.276 120.880 23.820
201909 19.714 123.175 25.216
201912 20.412 126.235 25.476
202003 17.362 124.705 21.935
202006 19.327 127.000 23.976
202009 22.580 130.118 27.341
202012 22.998 130.889 27.683
202103 21.962 131.771 26.259
202106 22.100 134.084 25.968
202109 23.251 135.847 26.966
202112 24.017 138.161 27.388
202203 26.178 138.822 29.710
202206 25.935 142.347 28.705
202209 28.607 144.661 31.156
202212 29.616 145.763 32.011
202303 31.307 146.865 33.585
202306 33.416 150.280 35.033
202309 35.091 151.492 36.495
202312 35.362 152.924 36.432
202403 39.437 153.035 40.601
202406 40.068 155.789 40.521
202409 43.272 157.882 43.181
202412 42.208 158.323 42.002
202503 42.675 157.552 42.675

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Poly Medicure  (BOM:531768) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Poly Medicure's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=2259.25/111.03
=20.35

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Poly Medicure was 29.39. The lowest was 15.43. And the median was 21.28.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Poly Medicure Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Poly Medicure's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Poly Medicure Business Description

Traded in Other Exchanges
Address
Okhla Industrial Estate, 232-B, 3rd Floor, Phase III, New Delhi, IND, 110020
Poly Medicure Ltd engages in the manufacturing and sale of medical devices. It offers disposable medical devices for infusion therapy, blood management, gastroenterology, vascular access, surgery and wound drainage, anesthesia, and urology. Some of its products include Ventilator Circuit Combo Kits, Bain Circuits, Safety Introducer Needles, High-Pressure Vaccum Bottle-Triplet, Catheters, and others. Geographically, it derives a majority of its revenue from exports. The company operates under one segment namely Medical Devices.

Poly Medicure Headlines

No Headlines